Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas (NCT06300528)

🔬

Loading study...

Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas (NCT06300528) | TrialReferrals